2013
DOI: 10.5606/tjr.2013.2916
|View full text |Cite
|
Sign up to set email alerts
|

A Possible Correlation Among Different Disease Activity Parameters and Functional Status in Patients with Ankylosing Spondylitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
0
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 22 publications
0
0
0
Order By: Relevance
“…Our cohort revealed higher mean ASDAS-CRP than mean ASDAS-ESR at both baseline and followup, which is consistent with a previous smaller study (12), although other studies have demonstrated lower ASDAS-CRP than ASDAS-ESR (9)(10)(11). In previous studies, the absolute difference between mean ASDAS-CRP and mean ASDAS-ESR ranged from zero (6)(7)(8) to one unit or above(9,10), while we found corresponding differences close to zero.…”
Section: Discussionsupporting
confidence: 91%
See 1 more Smart Citation
“…Our cohort revealed higher mean ASDAS-CRP than mean ASDAS-ESR at both baseline and followup, which is consistent with a previous smaller study (12), although other studies have demonstrated lower ASDAS-CRP than ASDAS-ESR (9)(10)(11). In previous studies, the absolute difference between mean ASDAS-CRP and mean ASDAS-ESR ranged from zero (6)(7)(8) to one unit or above(9,10), while we found corresponding differences close to zero.…”
Section: Discussionsupporting
confidence: 91%
“…However, ASDAS-ESR showed a trend to classify higher numbers of patients in lower disease activity states compared to ASDAS-CRP and lower numbers of patients in higher disease activity states(4). Thereafter, some studies have reported equal mean ASDAS scores(6-8), whereas others have observed differences (9)(10)(11)(12). Hence, there may be clinically relevant discrepancies between the two versions and consequently between their cut-off values for disease activity states, which could impact on treatment decisions in a treat-to-target regimen.…”
Section: Introductionmentioning
confidence: 99%